Candriam S.C.A. Quest Diagnostics Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Candriam S.C.A. holds 145,829 shares of DGX stock, worth $20 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

145,829

Previous 69,413 110.09%

Holding current value

$20 Million

Previous $9.5 Million 110.41%

% of portfolio

0.12%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$137.09 - $137.09 $10.5 Million - $10.5 Million	76,416 Added 110.09%	145,829 $20 Million
Q2 2024 Aug 05, 2024	BUY	$125.91 - $144.34 $1.25 Million - $1.43 Million	9,925 Added 16.68%	69,413 $9.5 Million
Q1 2024 May 03, 2024	SELL	$123.78 - $142.11 $5.37 Million - $6.16 Million	-43,359 Reduced 42.16%	59,488 $7.92 Million
Q4 2023 Feb 14, 2024	SELL	$120.62 - $141.12 $2.04 Million - $2.38 Million	-16,875 Reduced 14.1%	102,847 $14.2 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $2.18 Million - $2.6 Million	17,919 Added 17.6%	119,722 $14.6 Million
Q2 2023 Aug 08, 2023	SELL	$130.56 - $146.84 $4.53 Million - $5.09 Million	-34,666 Reduced 25.4%	101,803 $14.3 Million
Q1 2023 May 12, 2023	BUY	$131.53 - $155.76 $5.45 Million - $6.45 Million	41,398 Added 43.54%	136,469 $19.3 Million
Q4 2022 Feb 13, 2023	BUY	$123.31 - $157.26 $676,848 - $863,200	5,489 Added 6.13%	95,071 $14.9 Million
Q3 2022 Nov 10, 2022	BUY	$121.77 - $141.1 $3.52 Million - $4.08 Million	28,936 Added 47.71%	89,582 $11 Million
Q2 2022 Aug 03, 2022	BUY	$127.07 - $145.39 $2.54 Million - $2.9 Million	19,970 Added 49.1%	60,646 $8.06 Million
Q1 2022 May 13, 2022	BUY	$129.09 - $164.35 $210,287 - $267,726	1,629 Added 4.17%	40,676 $5.57 Million
Q4 2021 Feb 10, 2022	SELL	$140.36 - $173.01 $4.14 Million - $5.1 Million	-29,502 Reduced 43.04%	39,047 $6.76 Million
Q3 2021 Nov 09, 2021	SELL	$132.95 - $158.0 $258,720 - $307,468	-1,946 Reduced 2.76%	68,549 $9.96 Million
Q2 2021 Jul 20, 2021	BUY	$126.66 - $141.48 $1.83 Million - $2.05 Million	14,485 Added 25.86%	70,495 $9.3 Million
Q4 2020 Jan 22, 2021	BUY	$112.7 - $128.05 $1.94 Million - $2.2 Million	17,185 Added 44.26%	56,010 $6.67 Million
Q3 2020 Oct 19, 2020	SELL	$107.05 - $130.01 $214,956 - $261,060	-2,008 Reduced 4.92%	38,825 $4.45 Million
Q2 2020 Jul 23, 2020	BUY	$73.34 - $122.61 $480,597 - $803,463	6,553 Added 19.12%	40,833 $4.65 Million
Q4 2019 Jan 21, 2020	BUY	$100.29 - $107.99 $688,290 - $741,135	6,863 Added 25.03%	34,280 $4,000
Q3 2019 Oct 21, 2019	BUY	$97.85 - $107.42 $306,466 - $336,439	3,132 Added 12.9%	27,417 $3,000
Q2 2019 Aug 01, 2019	SELL	$85.18 - $101.94 $655,289 - $784,224	-7,693 Reduced 24.06%	24,285 $2.46 Million
Q1 2019 May 02, 2019	BUY	$80.68 - $89.92 $782,999 - $872,673	9,705 Added 43.57%	31,978 $3.86 Million
Q4 2018 Feb 14, 2019	BUY	$79.75 - $108.38 $604,824 - $821,953	7,584 Added 51.63%	22,273 $1.85 Million
Q3 2018 Nov 07, 2018	SELL	$105.42 - $114.99 $14.8 Million - $16.1 Million	-140,052 Reduced 90.51%	14,689 $1.59 Million
Q2 2018 Aug 14, 2018	SELL	$97.35 - $113.14 $2.38 Million - $2.77 Million	-24,450 Reduced 13.64%	154,741 $17 Million
Q1 2018 May 09, 2018	BUY	$96.42 - $107.88 $2.19 Million - $2.45 Million	22,701 Added 14.51%	179,191 $18 Million
Q4 2017 Feb 07, 2018	BUY	$90.86 - $100.24 $1.58 Million - $1.74 Million	17,363 Added 12.48%	156,490 $15.4 Million
Q3 2017 Nov 03, 2017	BUY	$91.96 - $108.35 $12.8 Million - $15.1 Million	139,127	139,127 $13 Million

Others Institutions Holding DGX

# of Institutions

933

Shares Held

93.8M

Call Options Held

501K

Put Options Held

238K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account